PRE-EXTENSIVELY DRUG RESISTANT (XDR) TB IN WISCONSIN Marathon County Population 134,700 1,545...
Preview:
Citation preview
- Slide 1
- Slide 2
- PRE-EXTENSIVELY DRUG RESISTANT (XDR) TB IN WISCONSIN Marathon
County Population 134,700 1,545 square miles Marathon County Health
Department 53 employees Tuberculosis in Marathon County 1-3 active
annual cases Case Resilience
- Slide 3
- PURPOSE OF PRESENTATION To educate and collaborate with other
professionals about my role as a public health tuberculosis case
manager. T RAINING O BJECTIVES To increase participant knowledge of
public health nurse case management role. To tell a story and give
a voice to Resilience. To collaborate with my colleagues by
answering questions and sharing knowledge & experiences.
- Slide 4
- The primary goals of TB case management are to render the
client non-infectious by ensuring appropriate treatment, prevent
additional transmission and development of additional disease,
identify and remove barriers to adherence, and identify and address
other urgent health needs. The health department role includes case
management, contact investigation, determination of infectiousness
(including release from isolation and return to normal
activity/locations), and oversight of treatment plan and outcome.
TB CASE MANAGEMENT
- Slide 5
- WHY RESILIENCE & NOT RESISTANCE? Being resilient doesnt
mean going through life without experiencing stress and pain.
People feel grief, sadness, and a range of other emotions after
adversity and loss. The road to resilience lies in working through
the emotions and effects of stress and painful events. Resilience
defined: We all experience adversity, from everyday changes and
challenges to serious losses. Fortunately, people are able to
adapt. Source:
http://www.pbs.org/thisemotionallife/topic/resilience/what-resiliencehttp://www.pbs.org/thisemotionallife/topic/resilience/what-resilience
- Slide 6
- MEET RESILIENCE? Resilience is a 69 year old Asian female
living in Marathon County with limited resources. Birthplace: Laos
Family: Eldest of 7 children Occupation: Farmer Spouse and
Children
- Slide 7
- HARDSHIP AND CHANGE Immigrated to the United States in
1990
- Slide 8
- THE CHAIN OF INFECTION Resilience visited a granddaughter for
1-2 weeks in March 2012. The father-in-law to this granddaughter
was diagnosed with active TB. Resilience reported she was not
screened for TB as she had only a small amount of exposure and no
symptoms.
- Slide 9
- RESILIENCES STORY, CONT. April 2012 - Living with and Uncle
& his wife and 4 children in Wausau for 6 months. June 18 th,
2012 - Resilience was diagnosed with right upper lobe pneumonia and
put on Azithromycin. November 2012 -Follow-up chest x-ray showed
improvement but not complete resolution of the infiltrate. -
Resilience traveled to California via plane to stay with family.
She had developed a cough and night sweats. - TST performed came
back negative. No follow up or additional testing performed.
February 2013 - Resilience lived on her own in 2 different
apartments in Marathon County since her return from
California.
- Slide 10
- TIMELINE June 18, 2012 1 st MD Office Visit Shortness of breath
with minimal exertion Abnormal chest X-ray (patchy and linear
opacity projecting over the right upper lobe, which was new from
prior exam from 01/18/2004) No fever, cough, or chills June 19,
2012 treated with a Z-Pak July 31, 2012 2 nd MD Office Visit
Continued shortness of breath with exertion Chest X-ray ordered,
but not followed up on
- Slide 11
- TIMELINE, CONT. November 15, 2012 3 rd MD Office Visit Right
breast pain x1 week Repeat chest X-ray, which was abnormal (mild
persistent infiltrate in the right upper lobe, which does not seem
as prominent as on the prior exam [06/18/2012]) Another Z-Pak
ordered April 19, 2013 4 th MD Office Visit Seen for elevated blood
pressure Another Z-Pak ordered
- Slide 12
- T IMELINE, CONT. July 1, 2013 Seen in Urgent Care Reports
history of headache and cough, both which have been ongoing for a
long time, with occasional productive cough Chest X-ray, which was
abnormal (right upper lobe segmental consolidation, suspected
malignancy; suggested CT scan) Sputum samples ordered for fungus,
etc. Primary provider follow-up suggested July 9, 2013 5 th MD
Office Visit Chronic cough and non-responsive to antibiotics.
Fever, chills, body aches, general malaise, productive cough
Started on Levofloxacin
- Slide 13
- T IMELINE, CONT. July 11, 2013 CT Scan Significantly abnormal
CT Scan (fairly extensive area of opacity involving the anterior
segment of the right upper lobe) TB cannot be excluded July 19,
2013 Pulmonary Consult Everything completed in a negative pressure
room. Positive QuantiFERON test
- Slide 14
- T IMELINE, CONT. July 22, 2013 Health Department Notified
Diagnostic & Treatment Center positive smears on 07/18/13 &
07/19/2013 Client placed in isolation by Health Department
Education provided, sputum samples collected & labs Consulted
with grandchildren, masks provided Contact investigation started
July 25, 2013 Removed from Isolation A patient can be presumed to
have an infection with non-tuberculosis mycobacteria pending
culture results, if a second specimen is smear positive and PCR
negative.
- Slide 15
- D EFINITIONS Multi-drug resistant (MDR): TB that is resistant
to at least INH and Rifampin Extensively drug resistant (XDR): TB
that is MDR Also resistant to any fluoroquinolone and at least one
of three injectable second-line drugs (i.e., amikacin, kanamycin,
or capreomycin ). Pre XDR-TB? 15
- Slide 16
- P RE XDR-TB TB disease caused by a TB strain resistant to
isoniazid and rifampin and either a fluoroquinolone or a
second-line injectable drug, but not both. 16
- Slide 17
- WLSH T ESTING Initial specimens received at WSLH Referred smear
POS specimen submitted from Diagnostic and Treatment Center in
Weston. Sputum specimen (DOC: 7/19/13) 3+ smear POS at DTC PCR
negative at WSLH Primary specimen also submitted at same time
Sputum. Smear POS @WSLH (1-9/oil immersion field) PCR negative
- Slide 18
- C ULTURE POSITIVE 4 th Sputum specimen collected on 7/23/13
SMEAR NEGATIVE at WLSH MGIT tube is POS on 8/12/13 HPLC shows M.
tuberculosis Complex
- Slide 19
- L ABORATORY T ESTING Specimen #DOCSmearPCRCulture
13mm41047/181-9/field (@WSLH) NEG(@WSLH)No AFB 13mm41057/193+
(@DTC)NEG(@WSLH)M. gordonae 13mm41037/22NEG (WSLH)Not doneM. tb
Complex 13mm41217/23NEGNot doneM. tb Complex 13mm41487/24NEGNot
doneNo AFB 13mm45238/151-9/100Not doneM. tb Complex
13mm45458/16NEGNot doneNo AFB 19
- Slide 20
- L AB T ESTING #2 Specimen #DOCSmearPCRCulture
13mm45658/17QuestionableNot doneNo AFB 13mm45688/18NEGNot doneM. tb
Complex 13mm47428/28NEGNot doneNo AFB 13mm47418/29NEGNot doneNo AFB
13mm49029/10NEGNot donePending 13mm49239/11NEGNot donePending
13mm49429/12NEGNot donePending 20
- Slide 21
- MDDR T ESTING @ CDC 13mm4121 M. tuberculosis Complex reported
on 8/14/13. Sent to CDC on 8/16/13 MDDR result received on 8/20/13
21
- Slide 22
- MDDR T ESTING @ CDC Resistant to: Rifampin INH Ethambutol
Kanamycin 22
- Slide 23
- MDDR T ESTING @ CDC Cannot rule out resistance PZA (Mutation
detected) Fluoroquinolone Other injectable drugs 23
- Slide 24
- P HENOTYPIC DST TESTING Began in-house Problematic due to
presence of M. gordonae in specimen IIRE results pending CDC: Agar
proportion testing First and second line drugs 24
- Slide 25
- CDC A GAR P ROPORTION RESULTS Resistance detected: Isoniazid
0.2/1.0/5.0 g/ml Rifampin 1.0 g/ml Ethambutol 5.0 g/ml Streptomycin
2.0/10.0 g/ml Rifabutin 2.0 g/ml Kanamycin 5.0 g/ml Capreomycin
10.0 g/ml Amikacin 4.0 g/ml
- Slide 26
- CDC A GAR P ROPORTION RESULTS #2 Susceptible Ciprofloxacin 2.0
g/ml Ethionamide 10.0 g/ml PAS 2.0 g/ml Ofloxacin 2.0 g/ml
- Slide 27
- O THER DST National Jewish Hospital in Denver MICs on
individual drugs Linezolid Moxifloxacin Cycloserine Imipenem
Azithromycin Clarithromycin
- Slide 28
- T IMELINE, CONT. August 16, 2013 Placed back into Isolation
Positive sputum culture collected on 07/23/2013 showing
Microbacterium Tuberculosis complex (WSLH specimen number
13MM4121). September 1, 2013 Emergency Room Visit Ambulance
Provider & Hospital No family in the area Concerns about
isolation Negative pressure room
- Slide 29
- T IMELINE, CONT. September 6, 2013 Program Manager Visit
Concerns about isolation Nursing home? Clan/Family Health
Department 4 visits/day x1 week, 3 visits/day ongoing; isolation
surveillance checks Family member to stay with client in the
evening September 9, 2013 6 th MD Visit In negative pressure room
MD against nursing home placement
- Slide 30
- T IMELINE, CONT. October 4, 2013 7 th MD Visit Client with
increased back and leg pain. Flu shot provided October 16, 2013 -
Update Isolation Compliance improved Judicare Energy Assistance
Stable at home waiting for treatment plan and then ID will do a
direct admit so a line can be placed and treatment started in the
hospital.
- Slide 31
- TIMELINE SUMMARY Total Primary Provider Visits: 5 X-Rays: 4
06/2012 07/2013 before TB was suspected
- Slide 32
- CONTACT INVESTIGATION Home Care employees tested 8/20 (2
adults) Neighbor tested 8/22 (2 adults) Wausau Family tested 8/23
negative (4 adults and 1 child) Wausau Family tested 8/28 negative
(2 adults and 4 children) Sacramento County Family referral 8/27 (2
adults and 3 children) Professional staff at Marshfield
Clinic.
- Slide 33
- CONTACT INVESTIGATION, CONT. Released from isolation 07/25/2013
08/14/2013 New exposure 07/25/13 referral made to Green Bay (1
adult and 1 child) New exposure 07/25/13 & 08/02/2013 2 staff
members Hospital visit grandson appendectomy 07/25/13 Health
Department Employees now asking how do we prevent further exposures
to staff in the future?
- Slide 34
- HELPING RESILIENCE IDENTIFY WITH HER NAME Factors that
contribute to Resilience: Close relationships with family and
friends A positive view of yourself and confidence in your
strengths and abilities The ability to manage strong feelings and
impulses Good problem-solving and communication skills Feeling in
control Seeking help and resources
- Slide 35
- HELPING RESILIENCE IDENTIFY WITH HER NAME Factors that
contribute to resilience: Seeing yourself as resilient, rather than
as a victim. Coping with stress in healthy ways and avoiding
harmful coping strategies, such as substance abuse. Helping others.
Finding positive meaning in your life despite difficult or
traumatic events. Source:
http://www.pbs.org/thisemotionallife/topic/resilience/what-resiliencehttp://www.pbs.org/thisemotionallife/topic/resilience/what-resilience
- Slide 36
- Source: Curry International Tuberculosis Center Tuberculosis
Drug Information Guide 2 nd edition A WORD ABOUT TREATING
DRUG-RESISTANT TUBERCULOSIS Hard data are often lacking to assist
clinicians in the management of drug-resistant TB. Many of the
drugs used to treat drug-resistant TB are not Food and Drug
Administration (FDA) licensed for these indications. Examples
include amikacin, all of the fluoroquinolones, and rifabutin.
Much-needed research is currently underway to more thoroughly
document the clinical efficacies of various treatment regimens for
drug-resistant TB and multidrug-resistant (MDR)-TB. Managing drug-
resistant TB is extremely challenging, and national guidelines call
for treatment of drug-resistant TB to be provided by or in close
consultation with experts.
- Slide 37
- QUESTIONS/COMMENTS Mary Hackel, R.N., B.S.N. Public Health
Nurse Marathon County Health Dept. Phone: 715-261-1945
Email:mary.hackel@co.marathon.wi.us
- Slide 38
- Nathan Woolever B.A. Senior Microbiologist Wisconsin State
Laboratory of Hygiene Phone: 608-262-1618 Email:
nathan.woolever@slh.wisc.edu